Schmidtova, Silvia http://orcid.org/0000-0003-4537-2062
Dorssers, Lambert C. J.
Kalavska, Katarina
Gillis, Ad J. M.
Oosterhuis, J. Wolter
Stoop, Hans
Miklikova, Svetlana
Kozovska, Zuzana
Burikova, Monika
Gercakova, Katarina
Durinikova, Erika
Chovanec, Michal
Mego, Michal
Kucerova, Lucia
Looijenga, Leendert H. J.
Funding for this research was provided by:
Agentúra na Podporu Výskumu a Vývoja (APVV-15-0086, APVV-15-0697, APVV-16-0178)
Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR (VEGA 1/0043/18)
Ministry of Health of the Slovak Republic (2018/39-LFUK-13)
Article History
Received: 5 May 2020
Accepted: 25 July 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: This article does not contain any studies with human participants performed by any of the authors. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. Studies involving mice were approved by the Institutional Ethic Committee and by the national competence authority (State Veterinary and Food Administration of the Slovak Republic), registration No. Ro 1976/17-221 in compliance with Directive 2010/63/EU of the European Parliament and the European Council and Regulation 377/2012 for the protection of animals used for scientific purposes. According to the national rules (Act no. 377/2012 Coll.) quail embryo can be used for experimentation without any ethical restrictions or prior protocol approval. It would not experience pain till the 14th day of its gestation period.
: All authors read and approved the final manuscript, and declare that they have no competing interest. A patent application has been filed covering the finding of using the presence of 3p amplification as a molecular marker to predict cisplatin resistance in germ cell tumors, and the possibility of alternative treatment options.